Genetic association of ABCA7 and PSEN1 polymorphisms with Alzheimer’s disease in the northeast Algerian population: Exploring risk factors
DOI:
https://doi.org/10.2298/ABS250208005AKeywords:
Alzheimer's disease, polymorphisms, ABCA7, PSEN1, northeast Algerian populationAbstract
Paper description:
- ABCA7 and PSEN1 genes are implicated in Alzheimer's disease (AD) susceptibility due to their role in β-amyloid accumulation and neurodegeneration. Investigating these variants in the Algerian population allows for the assessment of their contribution to AD risk in a distinct genetic context.
- A case-control study examined the association of ABCA7 rs3764650 and PSEN1 rs165932 with AD risk using PCR-RFLP genotyping.
- A significant association was found between rs3764650 and rs165932 and AD, particularly in late-onset cases and females.
- This study enhances understanding of AD genetics in the Algerian population, emphasizing the need for targeted studies and potential genetic screening.
Abstract: Alzheimer's disease (AD) is a neurodegenerative disorder with a strong genetic component. This research aims to identify the relationship between ABCA7 rs3764650, PSEN1 rs165932, and AD in the northeast Algerian population and investigate genetic risk factors contributing to disease susceptibility. A case-control study was performed with 98 patients and 156 controls. DNA was isolated from blood samples by salting out. Genotyping of ABCA7 and PSEN1 polymorphisms was conducted using PCR-RFLP. Significant associations were observed between ABCA7 rs3764650 and AD under dominant and additive models. Similarly, PSEN1 rs165932 was associated with a higher risk of AD under dominant, recessive, and additive models. The frequency of the ABCA7 G allele was significantly associated with PSEN1 T allele carriers (P=0.033), with no significant association observed in non-carriers. In contrast, the PSEN1 T allele frequency was significant in both ABCA7 G allele carriers (P=0.006) and non-carriers (P=0.001). Allelic frequencies for ABCA7 and PSEN1 were higher in late-onset cases (P=0.003; P< 0.001) and females (P=0.006; P< 0.001). This study highlights the association of the ABCA7 rs3764650 G and PSEN1 rs165932 T alleles with AD susceptibility, particularly in females and late-onset cases, suggesting their relevance as genetic markers of disease risk.
Downloads
References
Dos Santos LR, Pimassoni LHS, Sena GGS, Camporez D, Belcavello L, Trancozo M, Morelato RL, Errera FIV, Bueno MRP, de Paula F. Validating GWAS Variants from Microglial Genes Implicated in Alzheimer’s Disease. J Mol Neurosci. 2017;62(2):215-21. https://doi.org/10.1007/s12031-017-0928-7
Surguchev AA, Surguchov A. ABCA7—A Member of the ABC Transporter Family in Healthy and Ailing Brain. Brain Sciences. 2020;10(2):121. https://doi.org/10.3390/brainsci10020121
Insel PS, Hansson O, Mackin RS, Weiner M, Mattsson N. Amyloid pathology in the progression to mild cognitive impairment. Neurobiol Aging. 2018;64:76-84. https://doi.org/10.1016/j.neurobiolaging.2017.12.018
Ando K, Houben S, Homa M, de Fisenne M-A, Potier M-C, Erneux C, Brion J-P, Leroy K. Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis. Front Mol Neurosci. 2021;13:583755. https://doi.org/10.3389/fnmol.2020.583755
Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease. Mol Neurodegener. 2020;15(1):40. https://doi.org/10.1186/s13024-020-00391-7
Efthymiou AG, Goate AM. Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk. Mol Neurodegener. 2017;12:43. https://doi.org/10.1186/s13024-017-0184-x
Vogrinc D, Goričar K, Dolžan V. Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive Review. Front Aging Neurosci. 2021;13:646901. https://doi.org/10.3389/fnagi.2021.646901
Sáiz-Vazquez O, Puente-Martínez A, Pacheco-Bonrostro J, Ubillos-Landa S. Blood pressure and Alzheimer's disease: A review of meta-analysis. Front Neurol. 2023;13:1065335. https://doi.org/10.3389/fneur.2022.1065335
Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, Vargas-Rodriguez I, Cadena-Suarez AR, Sanchez-Garibay C, Pozo-Molina G, Mendez-Catala CF, Cardenas-Aguayo MD, Diaz-Cintra S, Pacheco-Herrero M, Luna-Munoz J, Soto-Rojas LO. Alzheimer's Disease: An Updated Overview of Its Genetics. Int J Mol Sci. 2023;24(4):3754. https://doi.org/10.3390/ijms24043754
Pires M, Rego AC. Apoe4 and Alzheimer's Disease Pathogenesis-Mitochondrial Deregulation and Targeted Therapeutic Strategies. Int J Mol Sci. 2023;24(1):778. https://doi.org/10.3390/ijms24010778
Kretzschmar GC, Alencar NM, da Silva SSL, Sulzbach CD, Meissner CG, Petzl-Erler ML, Souza RLR, Boldt ABW. GWAS-Top Polymorphisms Associated With Late-Onset Alzheimer Disease in Brazil: Pointing Out Possible New Culprits Among Non-Coding RNAs. Front Mol Biosci. 2021;8:632314. https://doi.org/10.3389/fmolb.2021.632314
Andrews SJ, Renton AE, Fulton-Howard B, Podlesny-Drabiniok A, Marcora E, Goate AM. The complex genetic architecture of Alzheimer's disease: novel insights and future directions. eBioMedicine. 2023;90:104511. https://doi.org/10.1016/j.ebiom.2023.104511
Chang Y-T, Hsu S-W, Huang S-H, Huang C-W, Chang W-N, Lien C-Y, Lee J-J, Lee C-C, Chang C-C. ABCA7 polymorphisms correlate with memory impairment and default mode network in patients with APOEε4-associated Alzheimer’s disease. Alz Res Therapy. 2019;11(1):103. https://doi.org/10.1186/s13195-019-0563-3
Aikawa T, Holm M-L, Kanekiyo T. ABCA7 and Pathogenic Pathways of Alzheimer’s Disease. Brain Sci. 2018;8(2):27. https://doi.org/10.3390/brainsci8020027
Liu D, Zhang H, Liu C, Liu J, Liu Y, Bai N, Zhou Q, Xu Z, Li L, Liu H. Systematic review and meta-analysis of the association between ABCA7 common variants and Alzheimer's disease in non-Hispanic White and Asian cohorts. Front Aging Neurosci. 2024;16:1406573. https://doi.org/10.3389/fnagi.2024.1406573
Talebi M, Delpak A, Khalaj-kondori M, Sadigh-Eteghad S, Talebi M, Mehdizadeh E, Majdi A. ABCA7 and EphA1 Genes Polymorphisms in Late-Onset Alzheimer’s Disease. J Mol Neurosci. 2020;70(2):167-73. https://doi.org/10.1007/s12031-019-01420-x
Ma F-C, Wang H-F, Cao X-P, Tan C-C, Tan L, Yu J-T. Meta-Analysis of the Association between Variants in ABCA7 and Alzheimer’s Disease. J Alz Dis. 2018;63(4):1261-7. https://doi.org/10.3233/JAD-180107
Le Guennec K, Nicolas G, Quenez O, Charbonnier C, Wallon D, Bellenguez C, Grenier-Boley B, Rousseau S, Richard A-C, Rovelet-Lecrux A, Bacq D, Garnier J-G, Olaso R, Boland A, Meyer V, Deleuze J-F, Amouyel P, Munter HM, Bourque G, Lathrop M, Frebourg T, Redon R, Letenneur L, Dartigues J-F, Pasquier F, Rollin-Sillaire A, Génin E, Lambert J-C, Hannequin D, Campion D, collaborators C-M, Hannequin D, Campion D, Wallon D, Martinaud O, Nicolas G, Rollin-Sillaire A, Bombois S, Mackowiak M-A, Deramecourt V, Pasquier F, Michon A, Le Ber I, Dubois B, Duyckaerts C, Godefroy O, Etcharry-Bouyx F, Chauviré V, Chamard L, Berger E, Magnin E, Dartigues J-F, Auriacombe S, Tison F, Goizet C, Sayette Vdl, Viader F, Castan D, Dionet E, Sellal F, Rouaud O, Thauvin C, Moreaud O, Sauvée M, Formaglio M, Mollion H, Roullet-Solignac I, Vighetto A, Croisile B, Didic M, Félician O, Koric L, Ceccaldi M, Gabelle A, Marelli C, Touchon J, Labauge P, Jonveaux T, Vercelletto M, Boutoleau-Bretonnière C, Castelnovo G, Renaud D, Robert P, Paquet C, Dumurgier J, Hugon J, De Boisgueheneuc F, Belliard S, Bakchine S, Sarazin M, Barrellon M-O, Laurent B, Blanc F, Tranchant C, Pariente J, Puel M, Hommet C, Mondon K. ABCA7 rare variants and Alzheimer disease risk. Neurology. 2016;86(23):2134-7. https://doi.org/doi:10.1212/WNL.0000000000002627
Vasquez JB, Fardo DW, Estus S. ABCA7 expression is associated with Alzheimer's disease polymorphism and disease status. Neurosci Lett. 2013;556:58-62. https://doi.org/10.1016/j.neulet.2013.09.058
Wang L, Jiao Y, Zhao A, Xu X, Ye G, Zhang Y, Wang Y, Deng Y, Xu W, Liu J. Analysis of Genetic Association Between ABCA7 Polymorphism and Alzheimer’s Disease Risk in the Southern Chinese Population. Front Aging Neurosci. 2022;14. https://doi.org/10.3389/fnagi.2022.819499
Kehoe P, Williams J, Lovestone S, Wilcock G, Owen MJ. Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group. Lancet. 1996;347(9009):1185-7. https://doi.org/10.1016/S0140-6736(96)90643-1
Akram Husain RS, Subramaniyan K, Ahmed SSSJ, Ramakrishnan V. Association of PSEN1 rs165932 polymorphism with Alzheimer's disease susceptibility: An extensive meta-analysis. Meta Gene. 2019;19:123-33. https://doi.org/10.1016/j.mgene.2018.11.007
Fan C, Huang X, Song H, Jia J. Presenilin 1 intronic polymorphism in sporadic Alzheimer’s disease in a Northern Chinese population. NeuroReport. 2020;31(1):37-40. https://doi.org/10.1097/WNR.0000000000001363
Diagnostic and statistical manual of mental disorders, 5th ed. American Psychiatric Association; 2013.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939-44. https://doi.org/10.1212/wnl.34.7.939
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215. https://doi.org/10.1093/nar/16.3.1215
Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J-C, Carrasquillo MM, Abraham R, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Jones N, Stretton A, Thomas C, Richards A, Ivanov D, Widdowson C, Chapman J, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Beaumont H, Warden D, Wilcock G, Love S, Kehoe PG, Hooper NM, Vardy ERLC, Hardy J, Mead S, Fox NC, Rossor M, Collinge J, Maier W, Jessen F, Schürmann B, Rüther E, Heun R, Kölsch H, van den Bussche H, Heuser I, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Gallacher J, Rujescu D, Giegling I, Goate AM, Kauwe JSK, Cruchaga C, Nowotny P, Morris JC, Mayo K, Sleegers K, Bettens K, Engelborghs S, De Deyn PP, Van Broeckhoven C, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Tsolaki M, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel K-H, Klopp N, Wichmann HE, Pankratz VS, Sando SB, Aasly JO, Barcikowska M, Wszolek ZK, Dickson DW, Graff-Radford NR, Petersen RC, van Duijn CM, Breteler MMB, Ikram MA, DeStefano AL, Fitzpatrick AL, Lopez O, Launer LJ, Seshadri S, Berr C, Campion D, Epelbaum J, Dartigues J-F, Tzourio C, Alpérovitch A, Lathrop M, Feulner TM, Friedrich P, Riehle C, Krawczak M, Schreiber S, Mayhaus M, Nicolhaus S, Wagenpfeil S, Steinberg S, Stefansson H, Stefansson K, Snædal J, Björnsson S, Jonsson PV, Chouraki V, Genier-Boley B, Hiltunen M, Soininen H, Combarros O, Zelenika D, Delepine M, Bullido MJ, Pasquier F, Mateo I, Frank-Garcia A, Porcellini E, Hanon O, Coto E, Alvarez V, Bosco P, Siciliano G, Mancuso M, Panza F, Solfrizzi V, Nacmias B, Sorbi S, Bossù P, Piccardi P, Arosio B, Annoni G, Seripa D, Pilotto A, Scarpini E, Galimberti D, Brice A, Hannequin D, Licastro F, Jones L, Holmans PA, Jonsson T, Riemenschneider M, Morgan K, Younkin SG, Owen MJ, O’Donovan M, Amouyel P, Williams J. Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease. Nat Genet. 2011;43(5):429-35. https://doi.org/10.1038/ng.803
Wang H-Z, Bi R, Hu Q-X, Xiang Q, Zhang C, Zhang D-F, Zhang W, Ma X, Guo W, Deng W, Zhao L, Ni P, Li M, Fang Y, Li T, Yao Y-G. Validating GWAS-Identified Risk Loci for Alzheimer’s Disease in Han Chinese Populations. Mol Neurobiol. 2016;53(1):379-90. https://doi.org/10.1007/s12035-014-9015-z
Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang L-S, Valladares O, Lin C-F, Larson EB, Graff-Radford NR, Evans D, De Jager PL, Crane PK, Buxbaum JD, Murrell JR, Raj T, Ertekin-Taner N, Logue M, Baldwin CT, Green RC, Barnes LL, Cantwell LB, Fallin MD, Go RCP, Griffith P, Obisesan TO, Manly JJ, Lunetta KL, Kamboh MI, Lopez OL, Bennett DA, Hendrie H, Hall KS, Goate AM, Byrd GS, Kukull WA, Foroud TM, Haines JL, Farrer LA, Pericak-Vance MA, Schellenberg GD, Mayeux R, Alzheimer Disease Genetics Consortium ft. Variants in the ATP-Binding Cassette Transporter (ABCA7), Apolipoprotein E ϵ4, and the Risk of Late-Onset Alzheimer Disease in African Americans. JAMA. 2013;309(14):1483-92. https://doi.org/10.1001/jama.2013.2973
Berg CN, Sinha N, Gluck MA. The Effects of APOE and ABCA7 on Cognitive Function and Alzheimer’s Disease Risk in African Americans: A Focused Mini Review. Front Hum Neurosci. 2019;13. https://doi.org/10.3389/fnhum.2019.00387
Cascorbi I, Flüh C, Remmler C, Haenisch S, Faltraco F, Grumbt M, Peters M, Brenn A, Thal DR, Warzok RW, Vogelgesang S. Association of ATP-binding cassette transporter variants with the risk of Alzheimer's disease. Pharmacogenomics. 2013;14(5):485-94. https://doi.org/10.2217/pgs.13.18
Ma F-C, Zong Y, Wang H-F, Li J-Q, Cao X-P, Tan L. ABCA7 genotype altered Aβ levels in cerebrospinal fluid in Alzheimer’s disease without dementia. Ann Transl Med. 2018;6(22):437. https://doi.org/10.21037/atm.2018.07.04
Vasquez JB, Simpson JF, Harpole R, Estus S. Alzheimer's Disease Genetics and ABCA7 Splicing. J Alz Dis. 2017;59(2):633-41. https://doi.org/10.3233/JAD-170872
Shulman JM, Chen K, Keenan BT, Chibnik LB, Fleisher A, Thiyyagura P, Roontiva A, McCabe C, Patsopoulos NA, Corneveaux JJ, Yu L, Huentelman MJ, Evans DA, Schneider JA, Reiman EM, De Jager PL, Bennett DA. Genetic Susceptibility for Alzheimer’s Disease Neuritic Plaque Pathology. JAMA Neurol. 2013;70(9):1150-7. https://doi.org/10.1001/jamaneurol.2013.2815
Kim WS, Li H, Ruberu K, Chan S, Elliott DA, Low JK, Cheng D, Karl T, Garner B. Deletion of Abca7 Increases Cerebral Amyloid-β Accumulation in the J20 Mouse Model of Alzheimer's Disease. J Neurosci. 2013;33(10):4387-94. https://doi.org/10.1523/JNEUROSCI.4165-12.2013
Wragg M, Hutton M, Talbot C. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group. Lancet. 1996;347(9000):509-12. https://doi.org/10.1016/s0140-6736(96)91140-x
Rodríguez-Manotas M, Amorín-Díaz M, Cañizares-Hernández F, Ruíz-Espejo F, Martínez-Vidal S, González-Sarmiento R, Martínez-Hernández P, Cabezas-Herrera J. Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism. Brain Research. 2007;1170:119-28. https://doi.org/10.1016/j.brainres.2007.07.032
Tilley L, Morgan K, Grainger J, Marsters P, Morgan L, Lowe J, Xuereb J, Wischik C, Harrington C, Kalsheker N. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease. Eur J Hum Genet. 1999;7(6):659-63. https://doi.org/10.1038/sj.ejhg.5200351
Abdala BB, Dos Santos JM, Goncalves AP, da Motta LB, Laks J, de Borges MB, Goncalves Pimentel MM, Santos-Reboucas CB. Influence of low-frequency PSEN1 variants on familial Alzheimer's disease risk in Brazil. Neurosci Lett. 2017;653:341-5. https://doi.org/10.1016/j.neulet.2017.05.053
Isoe K, Urakami K, Ji Y, Adachi Y, Nakashima K. Presenilin-1 polymorphism in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia in Japanese population. Acta Neurologica Scandinavica. 1996;94(5):326-8. https://doi.org/10.1111/j.1600-0404.1996.tb07074.x
Brooks WS, Kwok JBJ, Kril JJ, Broe GA, Blumbergs PC, Tannenberg AE, Lamont PJ, Hedges P, Schofield PR. Alzheimer's disease with spastic paraparesis and 'cotton wool' plaques: two pedigrees with PS-1 exon 9 deletions. Brain. 2003;126(Pt 4):783-91. https://doi.org/10.1093/brain/awg084
Ezquerra M, Blesa R, Tolosa E, Lopez Pousa S, Aguilar M, Peña J, Van Broeckhoven C, Ballesta F, Oliva R. The genotype 2/2 of the presenilin-1 polymorphism is decreased in Spanish early-onset Alzheimer's disease. Neurosci Lett. 1997;227(3):201-4. https://doi.org/10.1016/S0304-3940(97)00328-5
Zhu Y, Obregon D, Hou H, Giunta B, Ehrhart J, Fernandez F, Mori T, Nikolic W, Zhao Y, Morgan D, Town T, Tan J. Mutant presenilin-1 deregulated peripheral immunity exacerbates Alzheimer-like pathology. J Cell Mol Med. 2011;15(2):327-38. https://doi.org/10.1111/j.1582-4934.2009.00962.x
Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, Harvey RJ, Houlden H, Rossor MN, Collinge J. Early onset familial Alzheimer's disease: Mutation frequency in 31 families. Neurology. 2003;60(2):235-9. https://doi.org/10.1212/01.wnl.0000042088.22694.e3
Bagli M, Papassotiropoulos A, Schwab SG, Jessen F, Rao ML, Maier W, Heun R. No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer disease in a German population. Journal of the Neurological Sciences. 1999;167(1):34-6. https://doi.org/10.1016/s0022-510x(99)00131-8
Korovaitseva GI, Bukina A, Farrer LA, Rogaev EI. Presenilin polymorphisms in Alzheimer's disease. Lancet. 1997;350(9082):959. https://doi.org/10.1016/S0140-6736(05)63300-4
Romas SN, Mayeux R, Tang MX, Lantigua R, Medrano M, Tycko B, Knowles J. No association between a presenilin 1 polymorphism and Alzheimer disease. Arch Neurol. 2000;57(5):699-702. https://doi.org/10.1001/archneur.57.5.699
Xiao X, Liu H, Zhou L, Liu X, Xu T, Zhu Y, Yang Q, Hao X, Liu Y, Zhang W, Zhou Y, Wang J, Li J, Jiao B, Shen L, Liao X. The associations of APP, PSEN1, and PSEN2 genes with Alzheimer's disease: A large case-control study in Chinese population. CNS Neurosci Ther. 2023;29(1):122-8. https://doi.org/10.1111/cns.13987
Moreno DJ, Ruiz S, Ríos Á, Lopera F, Ostos H, Via M, Bedoya G. Association of GWAS Top Genes With Late-Onset Alzheimer’s Disease in Colombian Population. Am J Alzheimers Dis Other Demen. 2017;32(1):27-35. https://doi.org/10.1177/1533317516679303
Laws KR, Irvine K, Gale TM. Sex differences in the genetic predictors of Alzheimer’s pathology. Current Opin Psychiatry. 2018;31(2):133-9. https://doi.org/10.1097/YCO.0000000000000401
Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B, Bush WS, Gifford KA, Chibnik LB, Mukherjee S, De Jager PL, Kukull W, Crane PK, Resnick SM, Keene CD, Montine TJ, Schellenberg GD, Deming Y, Chao MJ, Huentelman M, Martin ER, Hamilton-Nelson K, Shaw LM, Trojanowski JQ, Peskind ER, Cruchaga C, Pericak-Vance MA, Goate AM, Cox NJ, Haines JL, Zetterberg H, Blennow K, Larson EB, Johnson SC, Albert M, for the Alzheimer’s Disease Genetics C, the Alzheimer’s Disease Neuroimaging I, Bennett DA, Schneider JA, Jefferson AL, Hohman TJ. Sex differences in the genetic predictors of Alzheimer’s pathology. Brain. 2019;142(9):2581-9. https://doi.org/10.1093/brain/awz206
Eissman JM, Dumitrescu L, Mahoney ER, Smith AN, Mukherjee S, Lee ML, Scollard P, Choi SE, Bush WS, Engelman CD, Lu Q, Fardo DW, Trittschuh EH, Mez J, Kaczorowski CC, Hernandez Saucedo H, Widaman KF, Buckley RF, Properzi MJ, Mormino EC, Yang HS, Harrison TM, Hedden T, Nho K, Andrews SJ, Tommet D, Hadad N, Sanders RE, Ruderfer DM, Gifford KA, Zhong X, Raghavan NS, Vardarajan BN, Alzheimer's Disease Neuroimaging I, Alzheimer's Disease Genetics C, Team AS, Pericak-Vance MA, Farrer LA, Wang LS, Cruchaga C, Schellenberg GD, Cox NJ, Haines JL, Keene CD, Saykin AJ, Larson EB, Sperling RA, Mayeux R, Cuccaro ML, Bennett DA, Schneider JA, Crane PK, Jefferson AL, Hohman TJ. Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease. Brain. 2022;145(7):2541-54. https://doi.org/10.1093/brain/awac177
Castro-Aldrete L, Moser MV, Putignano G, Ferretti MT, Schumacher Dimech A, Santuccione Chadha A. Sex and gender considerations in Alzheimer's disease: The Women's Brain Project contribution. Front Aging Neurosci. 2023;15:1105620. https://doi.org/10.3389/fnagi.2023.1105620
Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet. 2011;377(9770):1019-31. https://doi.org/10.1016/S0140-6736(10)61349-9
Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001;322(7300):1447-51. https://doi.org/10.1136/bmj.322.7300.1447
Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005;4(8):487-99. https://doi.org/10.1016/S1474-4422(05)70141-1
Lennon MJ, Makkar SR, Crawford JD, Sachdev PS. Midlife Hypertension and Alzheimer's Disease: A Systematic Review and Meta-Analysis. J Alzh Dis. 2019;71(1):307-16. https://doi.org/10.3233/JAD-190474
Chatterjee S, Mudher A. Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits. Front Neurosci. 2018;12. https://doi.org/10.3389/fnins.2018.00383
Hardy J, de Strooper B, Escott-Price V. Diabetes and Alzheimer's disease: shared genetic susceptibility? Lancet Neurol. 2022;21(11):962-4. https://doi.org/10.1016/S1474-4422(22)00395-7
Lee HJ, Seo HI, Cha HY, Yang YJ, Kwon SH, Yang SJ. Diabetes and Alzheimer's Disease: Mechanisms and Nutritional Aspects. Clin Nutr Res. 2018;7(4):229-40. https://doi.org/10.7762/cnr.2018.7.4.229
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Rayene Achou, Ouarda Sariyah Ayachi, Yasmina Boukhenaf, Rania Laouar, Razika Gharzouli, Abderrahim Mzahem, Houda Boulala, Noureddine Abadi, Dalila Satta
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
